<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - New Report Highlights Risks of U.S. Drug Reimportation
Image Overlay - New Report Highlights Risks of U.S. Drug Reimportation

Joint Oncologie and Merck Phase II Trial Announced for Gastric and Gastroesophageal Cancers

September 9, 2019

New Report Highlights Risks of U.S. Drug Reimportation

Oncologie and Merck will launch a phase II trial to investigate Merck’s Keytruda (pembrolizumab) and Oncologie’s bavituximab, an antibody that blocks the activity of phosphatidylserine (PS) in advanced gastric or gastroesophageal cancer. International trials like this one — enrolling patients in the United States, the UK, Korea, and Taiwan — are a particular specialty at Yourway.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Clinical Trial Supply Europe

February 24-26, 2026
Hyatt Regency, Barcelona Tower

Media

Articles

Why Alignment Matters in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?